Solabia Group Engages in New Growth Phase
Deal News | May 07, 2025 | ASTORG
Astorg, a prominent pan-European private equity firm, has signed an agreement to acquire a majority stake in Solabia Group, a provider of biotechnology ingredient solutions. The acquisition is from TA Associates, another leading global private equity firm, which will reinvest in Solabia and partner with Astorg in supporting the company's growth strategy. This plan centers on international market expansion and innovative product development, leveraging both organic growth and strategic mergers and acquisitions.
Sectors
- Private Equity
- Biotechnology
Geography
- Luxembourg – Luxembourg is part of Astorg's operational locations and contributes to its private equity activities.
- United Kingdom – London is one of Astorg’s bases and plays a role in this transaction.
- France – Paris is a key location for Astorg, involved in the transaction process for Solabia Group.
Industry
- Private Equity – Astorg and TA Associates are key participants in the private equity sector, involved in the acquisition of Solabia Group.
- Biotechnology – Solabia Group operates within the biotechnology industry, focusing on ingredient solutions.
Financials
- Not disclosed – Financial terms of the acquisition of Solabia Group by Astorg from TA Associates have not been disclosed.
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| Astorg | Bidding Company | Company | A leading pan-European private equity firm acquiring a majority stake in Solabia Group. |
| Solabia Group | Target Company | Company | A global biotechnology ingredient solutions provider undergoing acquisition. |
| TA Associates | Selling Company | Company | A global private equity firm selling its majority stake in Solabia Group but will reinvest and partner with Astorg. |